Physician profile
Radu Codel
NPI 1821082827
$5,390.20
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,307 · 2020: $910 · 2021: $1,821 · 2022: $1,278 · 2023: $74.01.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $778.34 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $699.30 | 2019-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $561.28 | 2019-2022 | |
| Boston Scientific Corporation | $363.82 | 2019-2022 | |
| Amarin Pharma, INC. | $353.38 | 2019-2022 | |
| Novo Nordisk INC | $344.04 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $282.23 | 2021-2023 | Trulance, Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.16 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $263.35 | 2019-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $249.35 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $235.55 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $206.57 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $201.36 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $152.73 | 2021-2022 | |
| Horizon Therapeutics Plc | $107.27 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $83.04 | 2019-2022 | |
| Esperion Therapeutics, INC. | $76.47 | 2021 | |
| Glaxosmithkline, LLC. | $39.68 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $33.63 | 2022 | |
| Lilly USA, LLC | $29.71 | 2019 | |
| Abbott Laboratories | $18.52 | 2022 | |
| Medicure Pharma INC. | $14.21 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.86 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radu Codel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.